Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...

Since the successful production of humanized antibodies in the 1980s, antibody-based medications have become increasingly essential in clinical treatment, taking advantage of their low immunogenicity ...

Recently, nanoparticle-driven 3D bioprinting has emerged as a revolutionary approach for high-throughput drug screening, offering enhanced scalability, accuracy, and efficiency while reducing reliance ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

Researchers have used a cutting-edge robotic system capable of synthesizing hundreds of metal complexes to develop a possible ...

This rapid screening process identified an iridium-based antibiotic candidate that shows promise in human cells to kill bacteria while remaining nontoxic.

(Nanowerk Spotlight) Scientists manipulating living cells face a fundamental challenge: working with thousands of samples at the nanoliter scale – volumes measured in billionths of a liter. At this ...